ホーム>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)

Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)

カタログ番号GC33930

デスアミノチロシン (3-(4-ヒドロキシフェニル) プロピオン酸) は、I 型インターフェロン シグナル伝達の増強を通じてインフルエンザから保護する微生物関連代謝産物です。

Products are for research use only. Not for human use. We do not sell to patients.

Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid) 化学構造

Cas No.: 501-97-3

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$50.00
在庫あり
100mg
$46.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Desaminotyrosine is a microbially associated metabolite protecting from influenza through augmentation of type I interferon signaling.

Wild-type mice produce nanomoles of Desaminotyrosine per gram of feces and have picomolar quantities of Desaminotyrosine in the serum. Desaminotyrosine (200 mM) treatment before influenza infection, protects from influenza by type I interferon (IFN) signaling, with no effect on weight loss or survival in mice with or without vancomycin, neomycin, ampicillin, and metronidazole (VNAM). Desaminotyrosine enhances type I IFN in macrophages via type I IFN amplification in mice[1].

[1]. Steed AL, et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science. 2017 Aug 4;357(6350):498-502.

レビュー

Review for Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.